Japan Bioanalysis Forum

The 11th JBF symposium will be held under the theme of "The beginning of a new era".

Date: February 25th to 27th, 2020.
Venue: Tower Hall Funabori, Tokyo, Japan
Detailed information will be updated as soon as it becomes available.

The program has been updated. here（26‐Dec.-2019）

NEW! The abstract has been released. here（15‐Jan.-2020）

The symposium will cover multidisciplinary topics on not only regulated bioanalysis but also cutting-edge technologies.
Preliminary program includes but not limited to:
  - Keynote lecture (Prof. Matsumura, National Cancer Center) - ICH M10 guideline
  - Artificial intelligence in bioanalysis and pharmacokinetics
  - Biomarker measurement in drug development
  - Anti-drug antibody testing in new modalities
  - Bioanalysis of DDS drug
  - Large molecule analytical technologies
  - Metabolite evaluation in clinical development
  - Practical solutions of troubles in LBA assay
  - Collaboration sessions with JSQA and clinical pharmacology
Outcomes and recommendations from JBF Discussion Groups will also be presented.

NEW! Extension of registration period
Registration (Dec.2nd - Jan. 24th,)[HERE] (17-Jan-2020)

Greetings from Chair of 11th JBF symposium [HERE]（12‐Dec.-2019）

Update JBF Archives 　:　 10th JBF Symposium Conference Report

See more

Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development was released in Japan .

Guideline on Bioanalytical Method Validation in Pharmaceutical Development (LC, small molecule) was released in Japan .

JBF updated 2nd version of “Guideline/Guidance Comparison on small molecule and LBA bioanalysis” among MHLW, EMA and FDA in accordance with the revision of FDA guidelines.(Dec,12,2018)

Please see the details.